The investigation and management of neonatal haemostasis and thrombosis

British Journal of Haematology

Volumn 119, Issue 2, 2002, Pages 295-309

  Williams, Michael D ^a   Chalmers, Elizabeth A ^b   Gibson, Brenda E S ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Anticoagulation; Bleeding disorders; Developmental haemostasis; Neonate; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; FIBRINOGEN; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEIN S; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TUBERCULOSTATIC AGENT; UROKINASE; VITAMIN K GROUP; WARFARIN;

ANAPHYLAXIS; ANTICOAGULANT THERAPY; BLEEDING; BLEEDING TIME; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD SAMPLING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; FAMILY HISTORY; FIBRINOLYSIS; HEALTH CARE POLICY; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HOMOZYGOSITY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MEDICAL RESEARCH; MEDLINE; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN S DEFICIENCY; PROTHROMBIN TIME; PUBLICATION; REVIEW; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOPHILIA; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VITAMIN K DEFICIENCY; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION DISORDERS, INHERITED; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRINOLYSIS; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA; THROMBOSIS; VITAMIN K DEFICIENCY;

EID: 0036440559     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03674.x     Document Type: Review

References (69)

1. Andrew, M., Paes, B., Milner, R., Johnson, M., Mitchell, L., Tollefsen, D.M. & Powers, P. (1987) Development of the coagulation system in the full-term infant. Blood, 70, 165-172.
2. Andrew, M., Paes, B., Milner, R., Johnston, M., Mitchell, L., Tollefsen, D.M., Castle, V. & Powers, P. (1988) Development of the human coagulation system in the healthy premature infant. Blood, 80, 1998-2005.
3. Andrew, M., Paes, B. & Johnston, M. (1990a) Development of the hemostatic system in the neonate and young infant. American Journal of Pediatric Hematology/Oncology, 12, 95-104.
4. Andrew, M., Paes, B., Bowker, J. & Vegh, P. (1990b) Evaluation of an automated bleeding time device in the newborn. American Journal of Hematology, 35, 275-277.
5. Andrew, M., Vegh, P., Caco, C., Kirplani, H., Jefferies, A., Ohlsson, A., Watts, J., Saigal, S., Milner, R. & Wang, E. (1993) A randomized controlled trial of platelet transfusions in thrombocytopenic premature infants. Journal of Paediatrics, 123, 285-291.
6. Andrew, M., David, M., Adams, M., Ali, K., Anderson, R., Barnard, D., Bernstein, M., Brisson, L., Cairney, B., DeSai, D., Grant, R., Israels, S., Jardine, L., Luke, B., Massicotte, P. & Silva, M. (1994a) Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood, 83, 1251-1257.
7. Andrew, M., Marzinotto, V., Massicotte, P., Blanchette, V., Ginsberg, J., Brill-Edwards, P., Burrows, P., Benson, L., Williams, W., David, M., Poon, A. & Sparling, K. (1994b) Heparin therapy in pediatric patients: A prospective cohort study. Pediatric Research, 35, 78-83.
8. Anwar, R. & Miloszewski, K.J.A. (1999) Factor XIII deficiency. British Journal of Haematology, 107, 468-484.
9. Bertina, R.M., Koelman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
10. Bick, R.L. (1995) Disseminated intravascular coagulation. Objective criteria for clinical and laboratory diagnosis and assessment of therapeutic response. Clinical Applied Thrombosis and Haemostasis, 1, 3-23.
11. Billio, A., Pstcosta, N., Rosanelli, C. & Amaddii, G. (1997) Successful short term oral surgery prophylaxis with rFVIIa in severe congenital factor VII deficiency. Blood Coagulation and Fibrinolysis, 8, 249-250.
12. Buchanan, G.B. (1999) Factor concentrate prophylaxis for neonates with haemophilia. Journal of Paediatric Haematology/Oncology, 21, 254-256.
13. Chalmers, E.A. & Gibson, B.E.S. (1999) Thrombolytic therapy in the management of paediatric thromboembolic disease. British Journal of Haematology, 104, 14-21.
14. Chouwdury, V., Lane, D.A., Mille, B., Auberger, K., Gandenberger-Bachem, S., Pabinger, I., Olds, R.J. & Thein, S.L. (1994) Homozygous antithrombin deficiency: Report of two new cases (99Leu to Phe) associated with venous and arterial thrombosis. Thrombosis and Haemostasis, 72, 198-202.
15. Cornelissen, M., Steegers-Theunissen, R., Kollee, L., Eskes, T., Vogels-Mentik, G., Motohara, K., De Abreu, R. & Monnens, L. (1993) Increased incidence of neonatal vitamin K deficiency resulting from maternal anti convulsant therapy. American Journal of Obstetrics and Gynaecology, 168, 923-928.
16. Cornelissen, M., von Kries, R., Loughnan, P. & Schubiger, G. (1997) Prevention of vitamin K deficiency bleeding: Efficacy of different multiple oral dose schedules of vitamin K. European Journal of Paediatrics, 156, 126-130.
17. Corrigan, J.J. (1989) Neonatal coagulation disorders. Perinatal Haematology, 21, 167.
18. Delgado-Escueta, A.V. & Janz, D. (1992) Consensus guidelines: Preconception counselling, management, and care of the pregnant woman with epilepsy. Neurology, 42, 149-160.
19. Dreyfus, M., Masterton, M., David, M., Rivard, G.E., Muller, F.-M., Kreuz, W., Beeg, T., Minford, A., Allgrove, J., Cohen, J.D., Christoph, J., Bergmann, F., Mitchell, V.E., Haworth, C., Nelson, K. & Schwarz, H.P. (1995) Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Seminars in Thrombosis and Haemostasis, 21, 371-381.
20. Eisele, B., Lamy, M., Thijs, L.G., Keinecke, H.O., Schuster, H.P., Matthias, F.R., Fourrier, F., Heinrichs, H. & Delvos, U. (1998) Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with anti-thrombin III in severe sepsis. Intensive Care Medicine, 24, 663-672.
21. Freed, M.D., Keane, J.F. & Rosenthal, A. (1974) The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation, 50, 565-569.
22. Girolami, A., De Marco, L., Dal, Bo, Zanon, R., Patrassi, R. & Cappellato, M.G. (1985) Rarer quantitative and qualitative abnormalities of coagulation. Clinics in Haematology, 14, 385-411.
23. Golding, J., Birmingham, K., Greenwood, R. & Mott, M. (1992) Intramuscular Vitamin K and childhood cancer. British Medical Journal, 305, 341-346.
24. Gunther, G., Junker, R., Strater, R., Schobess, R., Kurnik, K., Heller, C., Kosch, A. & Nowak-Gottl, U. for the Childhood Stroke Study Group (2000) Symptomatic ischaemic stroke in full-term neonates: Role of acquired and genetic prothrombotic risk factors. Stroke, 31, 2437-2441.
25. Haemostasis and Thrombosis Task Force (1994) Investigation and management of haemorrhagic disorders in pregnancy. Journal of Clinical Pathology, 47, 100-108.
26. Hansen, K.N. & Ebbesen, F. (1996) Neonatal vitamin K prophylaxis in Denmark: Three years' experience with oral administration during the first three months of life compared with one oral administration at birth. Acta Paediatrica, 85, 1137-1139.
27. Hathaway, W. & Corrigan, J. (1991) Report of Scientific and Standardisation Subcommittee on Neonatal Haemostasis. Normal coagulation data for fetuses and newborn infants. Thrombosis and Haemostasis, 65, 323-325.
28. Heller, C., Schobess, R., Kurnik, K., Junker, R., Günther, G., Kreuz, W. & Nowak-Göttl, U. (2000) Abdominal venous thrombosis in neonates and infants: Role of prothrombotic risk factors - A multicentre case-control study. British Journal of Haematology, 111, 534-539.
29. Hudson, I.R.B., Gibson, B.E.S., Brownlie, J., Holland, B.M., Turner, T.L. & Webber, R.W. (1990) Increased concentrations of D-Dimers in newborn infants. Archives of Disease in Childhood, 65, 383-389.
30. Jennings, I., Woods, T.A.L., Kitchen, S. & Preston, F.E. (2000) Detection of factor XIII deficiency: Which test? British Journal of Haematology, 108, 146a.
31. Junker, R., Koch, H.-G., Auberger, K., Münchow, N., Ehrenforth, S. & Nowak-Göttl, U. (1999) Prothrombin G20210A Gene Mutation and further prothrombotic risk factors in childhood thrombophilia. Arteriosclerosis and Thrombosis Vascular Biology, 19, 2568-2572.
32. Kulkarni, R. & Lusher, J.M. (1999) Intracranial and extracranial haemorrhages in newborns with haemophilia: A review of the literature. Journal of Paediatric Haematology/Oncology, 21, 289-295.
33. Lawson, S.E., Butler, D., Enayat, M.S. & Williams, M.D. (1999) Congenital thrombophilia and thrombosis: A study in a single centre. Archives of Disease in Childhood, 81, 176-178.
34. Leaker, M., Massicotte, P., Brooker, L.A. & Andrew, M. (1996) Thrombolytic therapy in pediatric patients: A comprehensive review of the literature. Thrombosis and Haemostasis, 76, 132-134.
35. Letsky, E. & Greaves, M. on behalf of the Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology (1996) Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. British Journal of Haematology, 95, 21-26.
36. McNinch, A.W. & Tripp, J.H. (1991) Haemorrhagic disease of the newborn in the British Isles: Two year prospective study. British Medical Journal, 303, 1105-1109.
37. Mahasandana, C., Veerakul, G., Tanphaichitr, V.S., Opartkiattikul, N. & Hathaway, W.E. (1996) Homozygous protein S deficiency: 7 Year follow-up. Thrombosis and Haemostasis, 76, 1122.
38. Manco-Johnson, M.J., Abshire, T.C., Jacobson, L.J. & Marlar, R.A. (1991) Severe neonatal protein C deficiency: Prevalence and thrombotic risk. Journal of Pediatrics, 119, 793-798.
39. Marlar, R.A. & Neumann, A. (1990) Neonatal purpura fulminans due to homozygous protein C or Protein S deficiencies. Seminars in Thrombosis and Haemostasis, 16, 299-310.
40. Massicotte, P., Adams, M., Marzinotto, V., Brooker, L.A. & Andrew, M. (1996) Low molecular weight heparin in pediatric patients with thrombotic disease: A dose finding study. Journal of Pediatrics, 128, 313-318.
41. Mingers, A.M., Philapitsch, A., Schwarz, H.P., Zeitler, P. & Kreth, H.W. (1998) Polymorphonuclear elastase in patients with homozygous type I plasminogen deficiency and ligneous conjunctivitis. Seminars in Thrombosis and Hemostasis, 24, 605-612.
42. Monagle, P., Andrew, M., Halton, J., Marlar, R., Jardine, L., Vegh, P., Johnston, M., Webber, C. & Massicotte, P. (1998) Homozygous protein C deficiency: Description of a new mutation and successful treatment with low molecular heparin. Thrombosis and Haemostasis, 79, 756-761.
43. Muller, F.M., Ehrenthal, W., Hafner, G. & Schranz, D. (1996) Purpura fulminans in severe congenital protein C deficiency: Monitoring of treatment with protein C concentrate. European Journal of Pediatrics, 155, 20-25.
44. National Committee for Clinical Laboratory Standards (1998) Collection, Transport and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays, 3rd edn. NCCLS document H21-A3, 18, 3.
45. Nohe, N., Flemmer, A., Rümler, R., Praun, M. & Auberger, K. (1999) The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: A report on 48 cases. European Journal of Pediatrics, 158, S134-S139.
46. Northern Neonatal Nursing Initiative (NNNI) Trial Group (1996a) A randomized trial comparing the effect of prophylactic intravenous fresh frozen plasma, gelatin or glucose on early mortality and morbidity in preterm babies. European Journal of Pediatrics, 155, 580-588.
47. Northern Neonatal Nursing Initiative (NNNI) Trial Group (1996b) Randomized trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: Outcome at two years. Lancet, 348, 229-232.
48. Ockelford, P.A. & Carter, C.J. (1982) Disseminated intravascular coagulation: The application and utility of diagnostic tests. Seminars in Thrombosis and Haemostasis, 8, 198-216.
49. Oh, W., Fanaroff, A.A., Verter, J., Stevenson, D.K., Papile, L.-A., Stoll, B.J., Lemons, J.A., Bauer, C.R. & Wright, L.L. (1996) Neonatal mortality and morbidity in very low birth weight infants: A seven year trend analysis of the Neonatal Network Data. Paediatric Research, 39, 235A.
50. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
51. Rickard, K.A. (1995) Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia, 1, 8-13.
52. Roberts, I.A.G. & Murray, N.A. (1999) Management of thrombocytopenia in neonates. British Journal of Haematology, 105, 864-870.
53. Roy, M., Turner-Gomes, S., Gill, G., Mernagh, J., Gillie, P. & Schmidt, B. (1997) Incidence and diagnosis of neonatal thrombosis associated with umbilical venous catheters. Thrombosis and Haemostasis, 78, PS2953.
54. Sadler, J.E. (1994) A revised classification of von Willebrand disease. Thrombosis and Haemostasis, 71, 520-525.
55. Schmidt, B. & Andrew, M. (for the subcommittee) (1992) Report of the Scientific and Standardization Subcommittee on Neonatal Hemostasis: Diagnosis and treatment of neonatal thrombosis. Thrombosis and Haemostasis, 67, 381-382.
56. Schmidt, B., Buchanan, M., Ofosu, F., Brooker, L., Hirsh, J. & Andrew, M. (1988) Antithrombotic properties of heparin in a neonatal piglet model of thrombin induced thrombosis. Thrombosis and Haemostasis, 60, 289-292.
57. Schwarz, H.P., Muntean, W., Watzke, H., Richter, B. & Griffin, J.H. (1988) Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood, 71, 562-565.
58. Sharon, C., Tirindelli, M.C., Mannucci, P.M., Tripodi, A. & Mariani, G. (1986) Homozygous protein C deficiency with moderately severe clinical symptoms. Thrombosis Research, 41, 483-488.
59. Smith, O.P., White, B. & Vaughan, D. (1997) Use of protein C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet, 35, 1590-1593.
60. Solano, C., Cobcroft, R.G. & Scott, D.C. (1990) Prediction of vitamin K response using the Echis time and the Echis-prothrombin time ratio. Thrombosis and Haemostasis, 64, 353-357.
61. Sutor, A.H. (1998) The bleeding time in paediatrics. Seminars in Thrombosis and Haemostasis, 24, 531-543.
62. Sutor, A.H., Massicotte, P., Leaker, M. & Andrew, M. (1997) Heparin therapy in paediatric patients. Seminars in Thrombosis and Haemostasis, 23, 303-319.
63. Sutor, A.H., von Kries, R., Cornelissen, E.A.M., McNinch, A.W. & Andrew, M. on behalf of the ISTH Paediatric/Perinatal Subcommittee (1999) Vitamin K Deficiency Bleeding (VKDB) in Infancy. Thrombosis and Haemostasis, 81, 456-461.
64. Tabbutt, S., Griswold, W.R., Ogino, M.T., Mendoza, A.E., Allen, J.B. & Reznik, V.M. (1994) Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. Journal of Perinatology, 14, 66-70.
65. United Kingdom Haemophilia Centre Directors Organisation Executive Committee (1997) Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders. Haemophilia, 3, 63-77.
66. US Department of Health and Human Services, Public Health Service and Agency Care Policy and Research (1992) Acute Pain Management: Operative or Medical Procedures and Trauma. Report AHCPR Pub. 92-0038, Agency for Health Care Policy and Research Publications.
67. Vailas, G.N., Brouillette, R.T., Scott, J.P., Shkolnik, A., Conway, J. & Wiringa, K. (1986) Neonatal aortic thrombosis: Recent experience. Journal of Pediatrics, 10, 101-108.
68. Walker, I.D., Greaves, M. & Preston, F.E. on behalf of the Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology (2001) Investigation and management of heritable thrombophilia. British Journal of Haematology, 114, 512-528.
69. Zipursky, A. (1999) Prevention of vitamin K deficiency in newborns. British Journal of Haematology, 104, 430-437.